Marco W. Schilham

6.9k total citations · 1 hit paper
99 papers, 5.3k citations indexed

About

Marco W. Schilham is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Marco W. Schilham has authored 99 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 32 papers in Oncology and 26 papers in Hematology. Recurrent topics in Marco W. Schilham's work include Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (24 papers) and CAR-T cell therapy research (23 papers). Marco W. Schilham is often cited by papers focused on Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (24 papers) and CAR-T cell therapy research (23 papers). Marco W. Schilham collaborates with scholars based in Netherlands, Germany and Switzerland. Marco W. Schilham's co-authors include Arjan C. Lankester, Hans Clevers, Wai‐Ping Fung‐Leung, Amin Rahemtulla, Thomas M. Kündig, Maarten J. D. van Tol, Bianca Heemskerk, Petra Moerer, Julia M. Potter and René E. M. Toes and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marco W. Schilham

96 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

1991 603 citations Amin Rahemtulla, Wai‐Ping Fung‐Leung et al. profile →

Peers

Countries citing papers authored by Marco W. Schilham

Since Specialization

Citations

This map shows the geographic impact of Marco W. Schilham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco W. Schilham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco W. Schilham more than expected).

Fields of papers citing papers by Marco W. Schilham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco W. Schilham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco W. Schilham. The network helps show where Marco W. Schilham may publish in the future.

Co-authorship network of co-authors of Marco W. Schilham

This figure shows the co-authorship network connecting the top 25 collaborators of Marco W. Schilham. A scholar is included among the top collaborators of Marco W. Schilham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco W. Schilham. Marco W. Schilham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients 2025 ·Bone Marrow Transplantation ·(unknown), (unknown), Erik B. van den Akker, Anja M. Jansen-Hoogendijk, Marco W. Schilham, Arjan C. Lankester, Gertjan Lugthart, Alexander B. Mohseny, Emilie P. Buddingh	0
2	Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study 2023 ·Blood Advances ·(unknown), Marco W. Schilham, (unknown), Anja M. Jansen-Hoogendijk, Cornelia M. Jol‐van der Zijde, Maarten J. D. van Tol, Robbert G. M. Bredius, Tayfun Güngör, Arjan C. Lankester, Dirk Jan A. R. Moes	6
3	IL-7 and IL-15 Levels Reflect the Degree of T Cell Depletion during Lymphopenia and Are Associated with an Expansion of Effector Memory T Cells after Pediatric Hematopoietic Stem Cell Transplantation 2021 ·The Journal of Immunology ·Katrine Kielsen, (unknown), (unknown), Anja M. Jansen-Hoogendijk, Monique M. van Ostaijen-ten Dam, Marianne Ifversen, Carsten Heilmann, Marco W. Schilham, Astrid G. S. van Halteren, Robbert G. M. Bredius, Arjan C. Lankester, Cornelia M. Jol‐van der Zijde, Maarten J. D. van Tol, Klaus Müller	10
4	Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation 2021 ·Cells ·Laura García-Pérez, (unknown), Marco W. Schilham, Arjan C. Lankester, Karin Pike‐Overzet, Frank J. T. Staal	13
5	NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Marijke Stigter‐van Walsum, (unknown), Monique M. van Ostaijen-ten Dam, Cornelis W. Tuk, Marco W. Schilham, C. René Leemans, Ruud H. Brakenhoff, Marjolein van Egmond, Rieneke van de Ven, Jantine E. Bakema	5
6	Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation? 2020 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Cornelia M. Jol‐van der Zijde, Anja M. Jansen-Hoogendijk, (unknown), Astrid G. S. van Halteren, Dirk Jan A. R. Moes, Robbert G. M. Bredius, (unknown), Frans J. Smiers, Maarten J. D. van Tol, Marco W. Schilham, Arjan C. Lankester	1
7	Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK Cells 2020 ·BIO-PROTOCOL ·Janine Melsen, Maria Themeli, (unknown), Els van Beelen, Gertjan Lugthart, Rob C. Hoeben, Marco W. Schilham, Harald Mikkers	4
8	An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis 2018 ·Arthritis & Rheumatism ·(unknown), Marco W. Schilham, Sylvia Kamphuis, P Müller, Arnd Heiligenhaus, Dirk Foell, Kirsten Minden, Roel A. Ophoff, Timothy R. D. J. Radstake, Anneke I. den Hollander, (unknown), Sanne Hiddingh, Nicoline E. Schalij‐Delfos, Joke H. de Boer, Sara L. Pulit, Jonas J. W. Kuiper	1
9	Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells 2015 ·Cancer Immunology Immunotherapy ·(unknown), Monique M. van Ostaijen-ten Dam, Kathelijne C.J.M. Kraal, Susy J. Santos, Lynne M. Ball, Arjan C. Lankester, Marco W. Schilham, R. Maarten Egeler, Maarten J. D. van Tol	23
10	Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ 2014 ·Journal of Experimental & Clinical Cancer Research ·Jens Pahl, Kitty M.C. Kwappenberg, Eleni Maria Varypataki, Susy J. Santos, Marieke L. Kuijjer, (unknown), Juul Wijnen, Maarten J. D. van Tol, Anne‐Marie Cleton-Jansen, R. Maarten Egeler, Wim Jiskoot, Arjan C. Lankester, Marco W. Schilham	73
11	The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease 2012 ·SHILAP Revista de lepidopterología ·Dagmar Berghuis, Marco W. Schilham, Susy J. Santos, Suvi Savola, Helen J. Knowles, Uta Dirksen, Karl‐Ludwig Schaefer, Jukka Vakkila, Pancras C.W. Hogendoorn, Arjan C. Lankester	37
12	High Titers of Pre-existing Adenovirus Serotype-Specific Neutralizing Antibodies in the Host Predict Viral Reactivation After Allogeneic Stem Cell Transplantation in Children 2011 ·Clinical Infectious Diseases ·Louise A. Veltrop‐Duits, Tamara van Vreeswijk, Bianca Heemskerk, Joyphi C. P. Thijssen, (unknown), (unknown), Eric C. J. Claas, Arjan C. Lankester, Maarten J. D. van Tol, Marco W. Schilham	38
13	Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors 2010 ·Virology ·Jeroen de Vrij, S K van den Hengel, Taco G. Uil, Danijela Koppers‐Lalic, (unknown), Oscar M. J. A. Stassen, Montserrat Bárcena, Masato Yamamoto, Corrina M.A. de Ridder, Robert Kraaij, Kitty M.C. Kwappenberg, Marco W. Schilham, Rob C. Hoeben	9
14	Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection 2010 ·Haematologica ·Maarten L. Zandvliet, J.H. Frederik Falkenburg, Ellis van Liempt, Louise A. Veltrop‐Duits, Arjan C. Lankester, Jayant Kalpoe, (unknown), Dirk M. van der Steen, Maarten J. van Tol, Roel Willemze, Henk‐Jan Guchelaar, Marco W. Schilham, Pauline Meij	54
15	Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction 2006 ·The Journal of Immunology ·Bianca Heemskerk, Tamara van Vreeswijk, Louise A. Veltrop‐Duits, Claudia C. Sombroek, Kees L. M. C. Franken, Renate M. Verhoosel, Pieter S. Hiemstra, Daphne van Leeuwen, Maaike E. Ressing, René E. M. Toes, Maarten J. D. van Tol, Marco W. Schilham	35
16	Human CD4⁺ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus 2006 ·European Journal of Immunology ·Louise A. Veltrop‐Duits, Bianca Heemskerk, Claudia C. Sombroek, Tamara van Vreeswijk, Sophie Gubbels, René E. M. Toes, Cornelis J.M. Melief, Kees L. M. C. Franken, Menzo Havenga, Maarten J. D. van Tol, Marco W. Schilham	36
17	Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells? 2005 ·Bone Marrow Transplantation ·Marco W. Schilham, Adriana Balduzzi, Peter Bader, (unknown)	12
18	Effect of Ribavirin on the Plasma Viral DNA Load in Patients with Disseminating Adenovirus Infection 2004 ·Clinical Infectious Diseases ·Arjan C. Lankester, Bianca Heemskerk, Eric C. J. Claas, Marco W. Schilham, Matthias F. C. Beersma, Robbert G. M. Bredius, Maarten J. D. van Tol, Aloys C.M. Kroes	94
19	Sox‐4 facilitates thymocyte differentiation 1997 ·European Journal of Immunology ·Marco W. Schilham, Petra Moerer, Ana Cumano, Hans Clevers	89
20	Generation of Mutant Mice Lacking Surface Expression of CD4 or CD8 Gene Targeting 1992 ·Advances in experimental medicine and biology ·Tak W. Mak, Amin Rahemtulla, Marco W. Schilham, (unknown), Wai‐Ping Fung‐Leung	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact